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Dosage and side effects of clozapine
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Background
Clozapine has decreased side effects burden compared
with conventional antipsychotics which leads to better
patient compliance and results in greater effectiveness.
The discovering of clozapine has shown that neurological
side effects are not obligatory when treating psychosis but
there's risk of agranulocytosis and some other side effects
(hypersalivation, sedation, weight gain etc.) The mean
dose of clozapine differs between Europe and the United
States and the side effects are often the limiting factor for
doctors when dosing clozapine.
Materials and methods
The sample included 104 in and out patients treated with
clozapine. Side-effects (number of leukocytes, sedation,
hypersalivation, dry mouth, extrapyramidal symptoma-
tology, blood pressure fall, maculopapular rush, vomiting
and weight gain) were identified with the use of clinical
examinations and laboratory analyses. The patients' diag-
noses were F20 (66%), F22 and F23 (12%), F25 (16%),
F31 and F32 (2%), and other (4%). Our investigation has
been carried out in three periods: 7 days after the begin-
ning of therapy, after two and after six months since the
beginning.
Results
The number of different side effects decreases during the
time, also as the frequency of registered side effects. The
patients did not report any severe or unexpected side-
effects. The mean dose of clozapine is not significantly
higher during those six months. The side effects are not
limiting factor when dosing clozapine.
Discussion
Clozapine was effective and safe drug for acute and long-
term treatment. Patients didn't report any severe or unex-
pected side effects. According to the published literature,
there are side-effects that we should examine also (cardiac
events, diabetes, and hyperlipidemia). In view of the
results, it is recommended that the treatment with clozap-
ine should be continually evaluated in the future, in order
to detect and prevent all side-effects connected with the
use of a widespread antipsychotic such as clozapine.
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